Michael Gelband’s Emergent Biosolutions EBS Stock Holding History

Michael Gelband’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$368K	Buy	+43,882	New	+$367K	﹤0.01%	1311
2025 Q2	–	Sell	-19,347	Closed	-$94K	–	1584
2025 Q1	$94K	Buy	+19,347	New	+$160K	﹤0.01%	1347
2023 Q4	–	Sell	-10,946	Closed	-$37K	–	1603
2023 Q3	$37K	Buy	+10,946	New	+$60.7K	﹤0.01%	1619
2022 Q3	–	Sell	-33,549	Closed	-$1.04M	–	1977
2022 Q2	$1.04M	Buy	+33,549	New	+$1.15M	0.01%	1062
2022 Q1	–	Sell	-9,545	Closed	-$415K	–	2301
2021 Q4	$415K	Buy	+9,545	New	+$432K	﹤0.01%	1512
2019 Q4	–	Sell	-7,379	Closed	-$386K	–	1615
2019 Q3	$386K	Buy	+7,379	New	+$344K	0.01%	774

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Michael Gelband's EBS Position: Q2 2026 in Review

Michael Gelband opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 43,882 shares worth $368K. The stake represents ﹤0.01% of the portfolio and ranks #1311 among its holdings. This is a return to the name: Michael Gelband previously reported a position in EBS as recently as Q1 2025.

Michael Gelband first reported a position in EBS in Q3 2019 and has held it in 6 quarters since. The position peaked at $1.04M in Q2 2022. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Michael Gelband held 43,882 shares of Emergent Biosolutions worth $368K as of Q2 2026.
Emergent Biosolutions was a new Michael Gelband position in Q2 2026.
Emergent Biosolutions made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1311 holding.
Michael Gelband first reported a position in Emergent Biosolutions in Q3 2019 and has held it in 6 quarters since.
Michael Gelband's Emergent Biosolutions position peaked at $1.04M in Q2 2022.
194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.